Colorectal Cancer Clinical Trial
Official title:
Efficacy of a Mobile Clinical Decision Support System (CaPtyVa CCR App) to Improve Performance of Gastroenterology and Coloproctology Specialists in Colorectal Cancer Screening and Surveillance According to Guideline Recommendations: A Randomized Clinical Trial.
This prospective study evaluates the use of a (Mobile Decision Support Systems), MDSS (CaPtyVa CCR app) in order to improves gastroenterology and coloproctology specialist's performance in CRC screening and surveillance according to local current guidelines.
The proper implementation of clinical practice guidelines (CPGs) has the potential to improve
health care quality and reduce costs by promoting the use of evidence-based interventions.
However, these benefits vary largely according to the way CPGs are put into effect. The
behavior of physicians towards CPGs is a determining factor in their successful
implementation. It has been suggested that physicians have difficulties in memorizing and
processing the complex information contained in CPGs.
Computer-Based Clinical Decision Support Systems (CDSSs) are defined as "any software
designed to aid in clinical decision making in which characteristics of individual patients
are matched to a computerized knowledge. These systems have shown to: improve prescribing
practices, reduce serious medication errors, enhance the delivery of preventive care
services, and improve adherence to recommended care standards.
Recent evidence had also suggests that mobile technologies could provide an effective
approach in order to allow these Decision Support Systems to be implemented (Mobile Decision
Support Systems, MDSS) without requiring personal computers or its integration into other
clinical information systems.
Colorectal cancer (CRC) is a global major medical and public health challenge, accounting for
881.000 deaths annually. Evidence-based CRC screening strategies have shown to be effective
in reducing CRC mortality. Hence, the majority of CRC deaths are believed to be the result of
CRC screening process breakdowns. Multiple studies report overuse and underuse of
colonoscopy, as well as poor physician's knowledge about CRC screening CPG's and their
inability to apply them in daily clinical practice. All these factors may threaten the
effectiveness of CRC screening programs.
The above mentioned problematic added to recent evidence showing a strong willingness of the
physicians to use mobile-based apps in order to assist them in making guideline-concordant
recommendations, motivated us to satisfy this need and we developed the first MDSS(CaPtyVa
CCR app), to assist physicians in the CRC screening and surveillance task process.
The aim of this prospective study is to evaluate whether a MDSS (CaPtyVa CCR app) improves
gastroenterology and coloproctology specialist's performance in CRC screening and
surveillance according to local current guidelines
A prospective, nationwide, single blinded, randomized study will be conducted. A 10-question
anonymous survey was created with CRC screening and surveillance clinical vignettes
reflecting real life daily practice scenarios. After the question were developed, they were
pre-tested and discussed for content and clarity by three experienced gastroenterologists.
Gastroenterologists and coloproctologists; randomly selected will be invited by e-mail to
participate in this study between May 2020 and June 2020.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
| Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
| Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
| Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
| Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
| Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
| Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
| Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
| Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
| Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
| Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
| Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
| Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |